Pullen JK - Search Results

1

Analysis of the Yersinia pestis V protein for the presence of linear antibody epitopes.

Pullen JK, Anderson GW Jr, Welkos SL, Friedlander AM. Pullen JK, et al. Infect Immun. 1998 Feb;66(2):521-7. doi: 10.1128/IAI.66.2.521-527.1998. Infect Immun. 1998. PMID: 9453605 Free PMC article.

2

Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis.

Andrews GP, Strachan ST, Benner GE, Sample AK, Anderson GW Jr, Adamovicz JJ, Welkos SL, Pullen JK, Friedlander AM. Andrews GP, et al. Among authors: pullen jk. Infect Immun. 1999 Mar;67(3):1533-7. doi: 10.1128/IAI.67.3.1533-1537.1999. Infect Immun. 1999. PMID: 10024607 Free PMC article.

3

Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.

Powell BS, Andrews GP, Enama JT, Jendrek S, Bolt C, Worsham P, Pullen JK, Ribot W, Hines H, Smith L, Heath DG, Adamovicz JJ. Powell BS, et al. Among authors: pullen jk. Biotechnol Prog. 2005 Sep-Oct;21(5):1490-510. doi: 10.1021/bp050098r. Biotechnol Prog. 2005. PMID: 16209555

4

Structural and functional characterization of a recombinant PorB class 2 protein from Neisseria meningitidis. Conformational stability and porin activity.

Minetti CA, Tai JY, Blake MS, Pullen JK, Liang SM, Remeta DP. Minetti CA, et al. Among authors: pullen jk. J Biol Chem. 1997 Apr 18;272(16):10710-20. doi: 10.1074/jbc.272.16.10710. J Biol Chem. 1997. PMID: 9099721 Free article.

5

Production of Haemophilus influenzae type-b porin in Escherichia coli and its folding into the trimeric form.

Pullen JK, Liang SM, Blake MS, Mates S, Tai JY. Pullen JK, et al. Gene. 1995 Jan 11;152(1):85-8. doi: 10.1016/0378-1119(94)00706-x. Gene. 1995. PMID: 7828934

6

Workshop report: Nucleic acid delivery devices for HIV vaccines: Workshop proceedings, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, May 21, 2015.

Weniger BG, Anglin IE, Tong T, Pensiero M, Pullen JK; Nucleic Acid Delivery Devices for HIV Vaccines Workshop Group. Weniger BG, et al. Among authors: pullen jk. Vaccine. 2018 Jan 25;36(4):427-437. doi: 10.1016/j.vaccine.2017.10.071. Epub 2017 Nov 22. Vaccine. 2018. PMID: 29174315

7

Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: what are the "cGMP"?

Sheets RL, Rangavajhula V, Pullen JK, Butler C, Mehra V, Shapiro S, Pensiero M. Sheets RL, et al. Among authors: pullen jk. Vaccine. 2015 Apr 8;33(15):1757-66. doi: 10.1016/j.vaccine.2015.02.003. Epub 2015 Feb 16. Vaccine. 2015. PMID: 25698494 Free PMC article. Review.

8

Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes.

Cassetti MC, McElhiney SP, Shahabi V, Pullen JK, Le Poole IC, Eiben GL, Smith LR, Kast WM. Cassetti MC, et al. Among authors: pullen jk. Vaccine. 2004 Jan 2;22(3-4):520-7. doi: 10.1016/j.vaccine.2003.07.003. Vaccine. 2004. PMID: 14670335

9

Establishment of an HLA-A*0201 human papillomavirus type 16 tumor model to determine the efficacy of vaccination strategies in HLA-A*0201 transgenic mice.

Eiben GL, Velders MP, Schreiber H, Cassetti MC, Pullen JK, Smith LR, Kast WM. Eiben GL, et al. Among authors: pullen jk. Cancer Res. 2002 Oct 15;62(20):5792-9. Cancer Res. 2002. PMID: 12384540

10

Recognition of a single amino acid change on the surface of a major transplantation antigen is in the context of self peptide.

Pullen JK, Tallquist MD, Melvold RW, Pease LR. Pullen JK, et al. J Immunol. 1994 Apr 1;152(7):3445-52. J Immunol. 1994. PMID: 8144927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters